Study Reports Clinical Benefits of Trinity Elite Cellular Bone Allograft

Orthofix Medical Trinity Fiberlock

Orthofix Medical announced results from a prospective, multicenter clinical study evaluating the safety and efficacy of the Trinity Elite™ cellular bone allograft (CBA) in lumbar spinal fusion. Patients treated with the Trinity Elite CBA demonstrated fusion rates of 98.6%, measured by bridging bone at 12 months follow-up.

In this open-label...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us